An Open-Label, Single Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profiles and Metabolite Identification of [14C]-Estetrol in Healthy Female Volunteers
Phase of Trial: Phase I
Latest Information Update: 27 May 2016
At a glance
- Drugs Estetrol (Primary)
- Indications Atrophic vaginitis; Breast cancer; Migraine; Osteoarthritis; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors Estetra S.A.
- 17 May 2016 Status changed from recruiting to completed.
- 29 Mar 2016 New trial record